Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

The goal of this clinical trial is to learn if cordyceps sinesis capsule (Bailiing Capsule) works to prevent the recurrence of microbiologically cured mycobacterium avium complex pulmonary disease in adults. The main questions it aims to answer are: Does cordyceps sinesis capsule (Bailiing Capsule) prevents the recurrence of mycobacterium avium complex pulmonary disease in adults? Researchers will compare cordyceps sinesis capsule (Bailiing Capsule) to a placebo (a look-alike substance that contains no drug) to see if cordyceps sinesis capsule helps to prevent the recurrence of mycobacterium avium complex pulmonary disease. Participants will: Take cordyceps sinesis capsule (Bailiing Capsule) or a placebo (a look-alike substance that contains no drug) for 12 months, both are administered every day. Visit the clinic once every 3 months for checkups and tests. Take online questionnaires every month.

NCT Number	NCT07174076
Lead Sponsor	Bin Cao Collaborators: China-Japan Friendship Hospital, Shanghai Pulmonary Hospital, Shanghai, China, Jiangxi Chest Hospital, Guangzhou Chest Hospital., Anhui Chest Hospital, Beijing Chest Hospital, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Mycobacterium Avium Complex Pulmonary Disease
Enrollment	300 participants
Start Date	2025-07-24
Primary Completion	2028-07-24 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-15